Influence of individualized dietary adaptation in patients undergoing hematopoietic stem cell transplantation. The ADITRAS study

被引:0
|
作者
Lavandeira, Uxia Rodriguez [1 ]
Rodriguez, Gloria Lugo [1 ]
Carreta, Juan Pio Torres [2 ]
Casariego, Alfonso Vidal [1 ]
机构
[1] Complexo Hosp Univ A Coruna, Serv Endocrinol & Nutr, Unicdad Nutr, As Xubias,84, La Coruna 15006, Spain
[2] Complexo Hosp Univ A Coruna, Serv Hematol, La Coruna, Spain
关键词
nutritional supplements; Hematopoietic stem-cell transplantation; Malnutrition; Diet; Oral; BODY-MASS INDEX; NUTRITIONAL-STATUS; CANCER; MALNUTRITION; ACCEPTANCE; GUIDELINES; INPATIENTS; SUPPORT;
D O I
10.20960/nh.04745
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: the objective of the study was to assess the efficacy of an individualized dietary adaptation to achieve nutritional requirements in patients undergoing hematopoietic stem cell transplantation (HSCT). Methodology: a pilot study of a nutritional intervention in patients undergoing HSCT. A nutritional assessment was performed the first 24 hours of admission and every 48-72 hours until discharge, or + 40 days after the transplant, making dietary adaptations. Results: 25 patients were recruited. According to MUST, 92.0 % (n = 23) were well nourished at the initial visit, with a loss of 2.1 (3.8) kg and a BMI of 26.4 kg/m(2)(4.2). Before HSCT, there was already a decrease in intake of 15.4 (23.5) % and in body weight of 0.2 (3.2) kg; after the HSCT, the weight loss was 3.4 (5.0) kg and the decrease in intake was 6.5 (30.4) %. The predominant symptoms were mucositis (60 %), nausea (60 %), and diarrhea (44 %). The diet was adapted in 100 % of the patients, 52 % received oral nutritional support (ONS) (n n = 13); enteral nutrition (EN) and parenteral nutrition (PN) were used only once. Conclusion: the nutritional status of patients undergoing HSCT is normal on admission but deteriorates during transplantation and prior conditioning. Dietary intervention is key to maintaining oral intake and reducing the risk of malnutrition.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 50 条
  • [1] Bone mass in patients undergoing hematopoietic stem cell transplantation.
    Sancho, JM
    Holgado, S
    Ribera, JM
    Granada, M
    Oriol, A
    Olive, A
    Batlle, M
    Valls-Roc, M
    Tena, X
    Milla, F
    Feliu, E
    BLOOD, 2002, 100 (11) : 849A - 849A
  • [2] Hemostatic alterations in patients undergoing hematopoietic stem cell transplantation.
    Buchholz, S
    Woywodt, A
    Scheer, J
    Hambach, L
    Kamal, H
    Haller, H
    Haubitz, M
    Ganser, A
    Hertenstein, B
    von Depka, M
    BLOOD, 2004, 104 (11) : 282A - 282A
  • [3] PHARMACOKINETICS OF TREOSULFAN IN PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION.
    ten Brink, M.
    Ackaert, O.
    Zwaveling, J.
    Bredius, R. G.
    Smiers, F. J.
    den Hartigh, J.
    Lankester, A. C.
    Guchelaar, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S100 - S101
  • [4] Preexisting cardiovascular disease in patients undergoing hematopoietic stem cell transplantation.
    Khayata, Mohamed
    Al-Kindi, Sadeer
    Njoroge, Linda
    De Lima, Marcos J. G.
    Oliveira, Guilherme H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] REACTIVATION OF CYTOMEGALOVIRUS IN PATIENTS UNDERGOING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION. RETROSPECTIVE UNICENTRIC STUDY
    Martinez Geijo, C.
    Velazquez Kennedy, K.
    Page Herraiz, I
    Martin Moro, F.
    Garcia Garcia, I
    Michael Fernandez, B.
    Sanz Ruperez, A.
    Ruiz Gomez, F.
    Lopez Jimenez, J.
    HAEMATOLOGICA, 2017, 102 : 202 - 202
  • [6] Telomere shortening in hematopoietic cells of patients undergoing alllogeneic stem cell transplantation.
    Engelhardt, M
    Guo, Y
    Finke, J
    BLOOD, 2000, 96 (11) : 762A - 763A
  • [7] Advance care planning among patients undergoing hematopoietic stem cell transplantation.
    Joffe, S
    Mello, M
    Lee, S
    BLOOD, 2003, 102 (11) : 81A - 81A
  • [8] Prospective investigation of hemostatic parameters in patients undergoing hematopoietic stem cell transplantation.
    Han, Yue
    Lu, Xiaoxu
    Wu, De Pei
    Sun, Aining
    BLOOD, 2006, 108 (11) : 418B - 418B
  • [9] Adenovirus Infections in Patients Undergoing Umbilical Cord Blood Hematopoietic Stem Cell Transplantation.
    Soriano, Gabriela
    Ho, Vincent T.
    Ballen, Karen K.
    Armand, Philippe
    Cutler, Corey
    Koreth, John
    Alyea, Edwin
    Soiffer, Robert J.
    Baden, Lindsey
    Antin, Joseph H.
    Marty, Francisco M.
    BLOOD, 2009, 114 (22) : 465 - 466
  • [10] CYCLOPHOSPHAMIDE POPULATION PHARM ACOKINETICS IN PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION.
    Brooks, J.
    Solans, B.
    Howard, K.
    Dvorak, C.
    Lalefar, N.
    Anderson, E.
    Lu, Y.
    Savic, R.
    Long-Boyle, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S30 - S30